Rani Therapeutics Faces Delisting Concerns
Ticker: RANI · Form: 8-K · Filed: Jun 26, 2025 · CIK: 1856725
| Field | Detail |
|---|---|
| Company | Rani Therapeutics Holdings, Inc. (RANI) |
| Form Type | 8-K |
| Filed Date | Jun 26, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
TL;DR
Rani Therapeutics might be delisted - stock alert!
AI Summary
Rani Therapeutics Holdings, Inc. filed an 8-K on June 26, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, and a transfer of listing. The report covers events as of June 20, 2025. The company is incorporated in Delaware and its principal executive offices are located at 2051 Ringwood Avenue, San Jose, California.
Why It Matters
This filing indicates potential issues with Rani Therapeutics' continued listing on an exchange, which could impact its stock liquidity and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's stock trading and overall financial stability.
Key Players & Entities
- Rani Therapeutics Holdings, Inc. (company) — Registrant
- June 20, 2025 (date) — Earliest event reported
- June 26, 2025 (date) — Date of report
- 2051 Ringwood Avenue, San Jose, California 95131 (location) — Principal executive offices
FAQ
What specific listing rule or standard has Rani Therapeutics failed to satisfy?
The filing states a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard' but does not specify the exact rule or standard in the provided text.
What is the date of the earliest event reported in this 8-K filing?
The earliest event reported is dated June 20, 2025.
What is the company's principal executive office address?
The company's principal executive offices are located at 2051 Ringwood Avenue, San Jose, California 95131.
What is the Commission File Number for Rani Therapeutics Holdings, Inc.?
The Commission File Number for Rani Therapeutics Holdings, Inc. is 001-40672.
What is the SIC code for Rani Therapeutics Holdings, Inc.?
The Standard Industrial Classification (SIC) code for Rani Therapeutics Holdings, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 26, 2025 regarding Rani Therapeutics Holdings, Inc. (RANI).